This is a preview of subscription content, log in via an institution to check access.
Reference
Lee S, et al. Comparison of cost-effectiveness of anti-epidermal growth factor receptor monoclonal antibody and anti-vascular endothelial growth factor monoclonal antibody in K-RAS WT, RAS WT, and RAS WT left-sided metastatic colorectal cancer. 22nd World Congress on Gastrointestinal Cancer : abstr. P-139, 1 Jul 2020. Available from: URL: https://www.sciencedirect.com/science/article/pii/S092375342039520X
Rights and permissions
About this article
Cite this article
Assessing cost effectiveness of targeted therapy in colorectal cancer. PharmacoEcon Outcomes News 859, 3 (2020). https://doi.org/10.1007/s40274-020-7012-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7012-1